The oversubscribed round was led by Middleland Capital's VTC Ventures with additional investment from Felton Group, LLC, Jobs Ohio Growth Capital Fund, Aztec Capital Management LLC, Cleveland Life Science Advisors, Valley Growth Ventures, LLC, Jump Start, Inc. and other investors. The raise will enable BIOHM's continued leadership as a data-driven, cutting-edge microbiome innovation partner for consumers, medical practitioners, and food, beverage and dietary supplement companies.

BIOHM is one of the world's leading microbiome companies utilizing microbiome data to create powerful new products and ingredients to help individuals live healthier lives. The first BIOHM FX probiotic supplement was designed to specifically help reduce digestive plaque found in the gut. BIOHM has since expanded their line of microbiome data-powered products to include more probiotic and prebiotic supplements, as well as a personalized Gut Test.